REPROS THERAPEUTICS INC. 4
4 · REPROS THERAPEUTICS INC. · Filed Feb 19, 2016
Insider Transaction Report
Form 4
PODOLSKI JOSEPH
DirectorChief Executive Officer
Transactions
- Purchase
Common Stock
2016-02-18$0.93/sh+10,000$9,300→ 87,422 total
Footnotes (1)
- [F1]75 shares are owned by certain family members of the reporting person.